[Hydroxyproline excretion in urine in chronic connective tissue disease].
D000324:Adrenocorticotropic Hormone / Q000627:therapeutic use; D000328:Adult; D000368:Aged; D000893:Anti-Inflammatory Agents / Q000627:therapeutic use; D001172:Arthritis, Rheumatoid / Q000652:urine; D003095:Collagen Diseases / Q000188:drug therapy / Q000652:urine*; D003882:Dermatomyositis / Q000652:urine; D004492:Edetic Acid / Q000627:therapeutic use; D005260:Female; D006801:Humans; D006909:Hydroxyproline / Q000652:urine*; D007213:Indomethacin / Q000627:therapeutic use; D008180:Lupus Erythematosus, Systemic / Q000652:urine; D008297:Male; D008875:Middle Aged; D010653:Phenylbutazone / Q000627:therapeutic use; D010488:Polyarteritis Nodosa / Q000652:urine; D011241:Prednisone / Q000627:therapeutic use; D011565:Psoriasis / Q000652:urine*; D012595:Scleroderma, Systemic / Q000652:urine; D013167:Spondylitis, Ankylosing / Q000652:urine
D000893:Anti-Inflammatory Agents; D000324:Adrenocorticotropic Hormone; D004492:Edetic Acid; D010653:Phenylbutazone; D006909:Hydroxyproline; D011241:Prednisone; D007213:Indomethacin
Die Hydroxyprolinausscheidung im Harn bei chronischen Krankheiten des Bindegewebes.